{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:07:07Z","timestamp":1791511627417,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"College of Health Sciences (CHS), Aspen Pharmacare, MRC"},{"name":"NRF"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jmgm.2017.06.026","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T16:34:34Z","timestamp":1498754074000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach"],"prefix":"10.1016","volume":"76","author":[{"given":"Z.K.","family":"Sanusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E.M.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Maseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.G.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Honarparvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2017.06.026_bib0005","series-title":"Basic HIV Virology, HIV Management in Australasia","first-page":"9","author":"Shehu-Xhilaga","year":"2009"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/312767a0","article-title":"T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV","volume":"312","author":"Klatzmann","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.6601823","article-title":"Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Gallo","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0020","unstructured":"HIV\/AIDS, J.U.N.P.o., and HIV\/AIDS, J.U.N.P.o. (2016) Global AIDS update 2016, Geneva, Switzerland."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cbdd.12063","article-title":"Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR","volume":"81","author":"Ahmed","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1107\/S0907444909054298","article-title":"Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes","volume":"66","author":"Robbins","year":"2010","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0035","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/bi100569u","article-title":"Computational study of the resistance shown by the subtype B\/HIV-1 protease to currently known inhibitors","volume":"49","author":"Genoni","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0040","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1128\/JVI.00726-08","article-title":"Active-site mutations in the South African human immunodeficiency virus type 1 subtype C protease have a significant impact on clinical inhibitor binding: kinetic and thermodynamic study","volume":"82","author":"Mosebi","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0045","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/cbdd.12262","article-title":"The impact of active site mutations of South African HIV PR on drug resistance: insight from molecular dynamics simulations, binding free energy and per-residue footprints","volume":"83","author":"Ahmed","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/cbdd.12690","article-title":"Binding free energy calculations of nine FDA-approved protease inhibitors against HIV-1 subtype C I36T? T containing 100 amino acids per monomer","volume":"87","author":"Lockhat","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0055","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/prot.24151","article-title":"Relation between flexibility and positively selected HIV-1 protease mutants against inhibitors","volume":"80","author":"Braz","year":"2012","journal-title":"Proteins: Struct. Funct. Bioinform."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0060","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1021\/jm900846f","article-title":"Synthesis of new thienyl ring containing HIV-1 protease inhibitors: promising preliminary pharmacological evaluation against recombinant HIV-1 proteases","volume":"53","author":"Bonini","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0065","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.vaccine.2007.12.023","article-title":"Rational design of novel HIV-1 entry inhibitors by RANTES engineering","volume":"26","author":"Vangelista","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0070","series-title":"Retroviruses: Molecular Biology, Genomics and Pathogenesis","author":"Kurth","year":"2010"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1039\/b208248a","article-title":"HIV-1 protease: mechanism and drug discovery","volume":"1","author":"Brik","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0080","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2174\/0929867023368890","article-title":"HIV protease inhibitors: peptidomimetic drugs and future perspectives","volume":"9","author":"Abdel-Rahman","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.med.53.052901.131947","article-title":"Rational approach to AIDS drug design through structural biology","volume":"53","author":"Wlodawer","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0090","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1080\/07391102.2012.736774","article-title":"Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance","volume":"31","author":"Naicker","year":"2013","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/14756366.2011.633907","article-title":"Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors","volume":"28","author":"Makatini","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bioorg.2011.08.002","article-title":"Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors","volume":"40","author":"Karpoormath","year":"2012","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0105","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/cmdc.201100512","article-title":"Pentacycloundecane-diol-based HIV-1 protease inhibitors: biological screening, 2D NMR, and molecular simulation studies","volume":"7","author":"Honarparvar","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0110","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1021\/bi020160i","article-title":"Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes","volume":"41","author":"Velazquez-Campoy","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0115","doi-asserted-by":"crossref","DOI":"10.1515\/hsz-2017-0107","article-title":"I36T? T mutation in South African subtype C (C-SA) HIV -1 protease significantly alters protease-drug interactions","author":"Maseko","year":"2017","journal-title":"Biol Chem"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/cr300314q","article-title":"Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity","volume":"114","author":"Honarparvar","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0125","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1110\/ps.0206402","article-title":"Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease","volume":"11","author":"Ohtaka","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0130","doi-asserted-by":"crossref","first-page":"12012","DOI":"10.1128\/JVI.78.21.12012-12021.2004","article-title":"Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor","volume":"78","author":"King","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0135","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1128\/JVI.02706-06","article-title":"Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations","volume":"81","author":"Muzammil","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1385\/CBB:44:3:395","article-title":"Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia","volume":"44","author":"Batista","year":"2006","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0145","series-title":"Exploring Chemistry with Electronic Structure Methods","first-page":"302","author":"Frisch","year":"1996"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0150","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1098\/rsta.2002.0993","article-title":"New challenges in quantum chemistry: quests for accurate calculations for large molecular systems","volume":"360","author":"Morokuma","year":"2002","journal-title":"Philos. Trans. R. Soc. Lond. A: Math. Phys. Eng. Sci."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-1280(98)00475-8","article-title":"A new ONIOM implementation in Gaussian98. Part I. The calculation of energies, gradients, vibrational frequencies and electric field derivatives","volume":"461","author":"Dapprich","year":"1999","journal-title":"J. Mol. Struct. THEOCHEM"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0160","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/1096-987X(200012)21:16<1419::AID-JCC1>3.0.CO;2-C","article-title":"On the application of the IMOMO (integrated molecular orbital+ molecular orbital) method","volume":"21","author":"Vreven","year":"2000","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0165","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10822-007-9144-9","article-title":"Rational design of an enzyme mutant for anti-cocaine therapeutics","volume":"22","author":"Zheng","year":"2008","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.theochem.2004.08.007","article-title":"Recognition of carboxylate and dicarboxylates by azophenol-thiourea derivatives: a theoretical host-guest investigation","volume":"686","author":"Ruangpornvisuti","year":"2004","journal-title":"J. Mol. Struct. THEOCHEM"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmgm.2015.11.010","article-title":"Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations","volume":"63","author":"Samanta","year":"2016","journal-title":"J. Mol. Graph. Modell."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.theochem.2004.10.052","article-title":"Molecular and electronic properties of HIV-1 protease inhibitor C 60 derivatives as studied by the ONIOM method","volume":"715","author":"Promsri","year":"2005","journal-title":"J. Mol. Struct. THEOCHEM"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0185","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1021\/ci800432s","article-title":"Assessment of QM\/MM scoring functions for molecular docking to HIV-1 protease","volume":"49","author":"Fong","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0190","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmgm.2007.04.009","article-title":"Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V\/L90M mutants based on QM and QM\/MM calculations","volume":"26","author":"Saen-oon","year":"2007","journal-title":"J. Mol. Graph. Modell."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1529\/biophysj.104.046110","article-title":"Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations","volume":"88","author":"Wittayanarakul","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0200","first-page":"2791","article-title":"Molecular dynamics simulations on the role of protonation states in HIV-1 protease-indinavir complex","volume":"67","author":"Shi","year":"2009","journal-title":"Acta Chim. Sin."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0205","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1142\/S0219633609005313","article-title":"Quantum calculation of protein solvation and protein-ligand binding free energy for hiv-1 protease\/water complex","volume":"8","author":"Tong","year":"2009","journal-title":"J. Theor. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0210","series-title":"Design, Synthesis and Screening of Novel PCU-Peptide\/Peptoid Derived HIV Protease Inhibitors","author":"Makatini","year":"2011"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0215","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nsb1196-946","article-title":"Ionization states of the catalytic residues in HIV-1 protease","volume":"3","author":"Smith","year":"1996","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-015-0115-5","article-title":"Pentacycloundecane lactam vs lactone norstatine type protease HIV inhibitors: binding energy calculations and DFT study","volume":"22","author":"Honarparvar","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0225","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1021\/jp010637k","article-title":"Theoretical study of molecular structure, tautomerism, and geometrical isomerism of moxonidine: two-layered ONIOM calculations","volume":"105","author":"Remko","year":"2001","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.comptc.2012.03.002","article-title":"Theoretical study on the mechanism and stereochemistry of salicylaldehyde-Al (III)-catalyzed hydrophosphonylation of benzaldehyde","volume":"989","author":"Li","year":"2012","journal-title":"Comp. Theor. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0235","first-page":"160","article-title":"The L33F darunavir resistance mutation acts as a molecular anchor reducing the flexibility of the HIV-1 protease 30s and 80s loops","volume":"2","author":"Kuiper","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbrc.2013.06.027","article-title":"Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: mechanism of drug recognition and resistance","volume":"437","author":"Liu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbrc.2012.12.127","article-title":"Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex","volume":"431","author":"Liu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0250","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1021\/jm500402c","article-title":"Structural basis for HTLV-1 protease inhibition by the HIV-1 protease inhibitor indinavir","volume":"57","author":"Kuhnert","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0255","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/pro.2019","article-title":"Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors","volume":"21","author":"Tie","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0260","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jmb.2007.09.083","article-title":"Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants","volume":"374","author":"Ko\u017e\u00ed\u0161ek","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0265","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1128\/AAC.00107-14","article-title":"A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIV","volume":"58","author":"Yedidi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0270","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/cb300191k","article-title":"Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease","volume":"7","author":"King","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0275","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1021\/jm00172a002","article-title":"Structure-based, C2 symmetric inhibitors of HIV protease","volume":"33","author":"Kempf","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0280","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0285","series-title":"4.0 Tutorials, Receptor-Ligand Interaction","author":"Studio","year":"2013"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0290","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0295","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/prot.20660","article-title":"Very fast empirical prediction and rationalization of protein pKa values","volume":"61","author":"Li","year":"2005","journal-title":"Proteins: Struct. Funct. Bioinform."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0300","unstructured":"http:\/\/nbcr-222.ucsd.edu\/pdb2pqr_2.0.0\/."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0305","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0310","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/prot.20497","article-title":"Comparing protein-ligand docking programs is difficult","volume":"60","author":"Cole","year":"2005","journal-title":"Proteins: Struct. Funct. Bioinform."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0315","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/jmbi.1999.3371","article-title":"Knowledge-based scoring function to predict protein-ligand interactions","volume":"295","author":"Gohlke","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0320","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/jm0302997","article-title":"Evaluation of docking performance: comparative data on docking algorithms","volume":"47","author":"Kontoyianni","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0325","series-title":"GaussView, Version 5","author":"Dennington","year":"2009"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0330","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1021\/jp960669l","article-title":"Density functional theory of electronic structure","volume":"100","author":"Kohn","year":"1996","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00268979600100011","article-title":"Exchange functionals and potentials","volume":"87","author":"Neumann","year":"1996","journal-title":"Mol. Phys."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0340","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0345","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the colle-salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0350","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00533485","article-title":"The influence of polarization functions on molecular orbital hydrogenation energies","volume":"28","author":"Hariharan","year":"1973","journal-title":"Theor. Chim. Acta"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0355","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1063\/1.476673","article-title":"6-31G* basis set for atoms K through Zn","volume":"109","author":"Rassolov","year":"1998","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0360","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1574-1400(06)02003-2","article-title":"Hybrid methods: oniom (QM: MM) and QM\/MM","volume":"2","author":"Vreven","year":"2006","journal-title":"Ann. Rep. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0370","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1073\/pnas.91.9.4096","article-title":"L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor","volume":"91","author":"Vacca","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0375","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/jm9704098","article-title":"Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease","volume":"40","author":"Kaldor","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0380","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1063\/1.472065","article-title":"The IMOMO method: integration of different levels of molecular orbital approximations for geometry optimization of large systems: test for n-butane conformation and SN2 reaction: RCl+ Cl-","volume":"105","author":"Humbel","year":"1996","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0385","doi-asserted-by":"crossref","first-page":"19357","DOI":"10.1021\/jp962071j","article-title":"ONIOM: a multilayered integrated MO+ MM method for geometry optimizations and single point energy predictions A test for diels-alder reactions and Pt(P(t-Bu)3)2+ H2 oxidative addition","volume":"100","author":"Svensson","year":"1996","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0390","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1021\/ja953846p","article-title":"H2XO and (CH3)2XO Compounds (X=C, Si, Ge, Sn, Pb): double bonds vs carbene-like structures can the metal compounds exist at all?","volume":"118","author":"Kapp","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0395","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1063\/1.464906","article-title":"The performance of a family of density functional methods","volume":"98","author":"Johnson","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0400","series-title":"09, Revision D.01","author":"Frisch","year":"2009"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0405","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1021\/cr5004419","article-title":"The ONIOM method and its applications","volume":"115","author":"Chung","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0410","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1021\/ct100029p","article-title":"Case studies of ONIOM (DFT: DFTB) and ONIOM (DFT: DFTB: MM) for enzymes and enzyme mimics","volume":"6","author":"Lundberg","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0415","series-title":"Thermochemistry in Gaussian","first-page":"1","author":"Ochterski","year":"2000"},{"key":"10.1016\/j.jmgm.2017.06.026_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6807-3-2","article-title":"Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations","volume":"3","author":"Jenwitheesuk","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0425","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1110\/ps.03468904","article-title":"HIV-1 protease molecular dynamics of a wild-type and of the V82F\/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs","volume":"13","author":"Perryman","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0430","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1110\/ps.33202","article-title":"Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations","volume":"11","author":"Freedberg","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2017.06.026_bib0435","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1039\/C4MD00057A","article-title":"A fundamental view of enthalpy-entropy compensation","volume":"5","author":"Ryde","year":"2014","journal-title":"MedChemComm"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332631730253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332631730253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:54:55Z","timestamp":1761080095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332631730253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":87,"alternative-id":["S109332631730253X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.06.026","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}